Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease

This publication has 61 references indexed in Scilit:

• Adenosine signaling and the regulation of chronic lung disease
  Pharmacology & Therapeutics, 2009
• A₃Adenosine Receptor Signaling Influences Pulmonary Inflammation and Fibrosis
  American Journal of Respiratory Cell and Molecular Biology, 2008
• Finding better therapeutic targets for patients with asthma: adenosine receptors?
  British Journal of Pharmacology, 2008
• Treating lung inflammation with agonists of the adenosine A_2Areceptor: promises, problems and potential solutions
  British Journal of Pharmacology, 2008
• Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
  Nature Reviews Drug Discovery, 2008
• A_2B Adenosine Receptors Regulate the Mucus Clearance Component of the Lung's Innate Defense System
  American Journal of Respiratory Cell and Molecular Biology, 2008
• Progress in the discovery of selective, high affinity A2B adenosine receptor antagonists as clinical candidates
  Purinergic Signalling, 2008
• Enhanced mast cell activation in mice deficient in the A2b adenosine receptor
  The Journal of Experimental Medicine, 2007
• Adenosine A1 receptor antagonist versus montelukast on airway reactivity and inflammation
  European Journal of Pharmacology, 2006
• A₃Adenosine Receptor Signaling Contributes to Airway Mucin Secretion after Allergen Challenge
  American Journal of Respiratory Cell and Molecular Biology, 2006